[4 years of direct-acting antivirals (DAAs) in the German Hepatitis C-Registry (DHC-R)]

Dietrich Hüppe1, Yvonne Serfert2, Peter Buggisch3

  • 1Gastroenterologische Gemeinschaftspraxis Herne, Herne.

Zeitschrift Fur Gastroenterologie
|January 15, 2019
PubMed
Abstract

Insights

The German Hepatitis C Registry (DHC-R) shows new antiviral treatments for chronic hepatitis C are highly effective and safe in real-world German patient care. Registry data confirms excellent tolerability and sustained virological response rates.

Area of Science:

  • Hepatology
  • Virology
  • Public Health

Background:

  • Chronic hepatitis C affects over 250,000 individuals in Germany.
  • Recent approval of potent direct-acting antiviral drugs has transformed treatment landscapes.
  • The German Hepatitis C-Registry (DHC-R) was established to monitor patient care and treatment outcomes.

Purpose of the Study:

  • To describe the epidemiology of hepatitis C in Germany.
  • To evaluate patient care patterns for chronic hepatitis C.
  • To assess the real-world efficacy and safety of newly approved antiviral therapies.

Main Methods:

  • Prospective, multicenter, non-interventional registry study across 327 German centers.
  • Documentation of all approved hepatitis C treatment options.
  • Analysis divided into four distinct time phases from February 2014 to July 2018.

Main Results:

  • Over 11,000 patients initiated antiviral treatment between 2014 and 2018.
  • Mean patient age decreased, while the proportion with a history of drug abuse increased.
  • Significant reduction in liver cirrhosis prevalence among treated patients.
  • Sustained virological response rates exceeded 94% with excellent tolerability.

Conclusions:

  • The DHC-R effectively reflects real-world hepatitis C patient management in Germany.
  • The registry provides valuable insights into evolving hepatitis C epidemiology.
  • Novel antiviral treatments demonstrate high efficacy and safety in clinical practice.

Related Concept Videos

Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.9K
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.7K
Adrenergic Agonists: Direct-Acting Agents01:30

Adrenergic Agonists: Direct-Acting Agents

Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
2.8K
Direct-Acting Cholinergic Agonists: Pharmacological Actions00:59

Direct-Acting Cholinergic Agonists: Pharmacological Actions

Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
2.3K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
2.1K
Forces Acting on Chromosomes02:11

Forces Acting on Chromosomes

During mitosis, chromosome movements occur through the interplay of multiple piconewton level forces. In prometaphase, these forces help in chromosome assembly or congression at the equatorial plane, eventually leading to their alignment at the metaphase plate. The forces acting on the chromosomes are space and time-dependent; therefore, they vary with the position of the chromosomes as the cell progresses through mitosis. 
Microtubules and motor proteins exert two types of forces on...
3.9K